Andrew Kung
10Patents
2h-index
11Co-inventors
51Inventor score
Filing activity: Jun 2, 2000 → Jul 23, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6986881B1 | Identification of compounds that modify transcriptional responses to hypoxia | Human Necessities | 7 | Expired |
| US7399851B2 | Composition and method for imaging cells | Chemistry; Metallurgy | 2 | Expired |
| US8841067B2 | NOL3 is a predictor of patient outcome | Physics | 1 | Active |
| US10329626B2 | NOL3 is a predictor of patient outcome | Physics | 0 | Active |
| US9533980B2 | NOL3 is a predictor of patient outcome | Physics | 0 | Active |
| US7781393B2 | Methods for inhibiting tumor cell growth | Human Necessities | 0 | Expired |
| US7892767B2 | Phosphospecific chemokine receptor antibodies | Human Necessities | 0 | Active |
| US12033727B2 | Managing and accessing experiment data using referential indentifiers | Physics | 0 | Active |
| US7732658B2 | Composition and method for imaging cells | Chemistry; Metallurgy | 0 | Active |
| US8999661B2 | Compositions for detecting cell death and methods of use thereof | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.